ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.65
-0.26%
US Tech 100
19,168.00
0.52%
S&P 500
5,431.60
-0.04%
US Dollar vs CAD
1.37515
-0.01%
Bitcoin
66,028.99
0.04%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Pyxis Oncology Inc (PYXS)

  7. Pyxis Oncology Inc (PYXS) News

PYXS

Pyxis Oncology (PYXS)

Pyxis Oncology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PYXS
DateTimeSourceHeadlineSymbolCompany
06/12/20243:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
06/10/20246:56AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
06/10/20246:30AMGlobeNewswire Inc.Pyxis Oncology Expands Board of Directors with Appointment of Michael A. MetzgerNASDAQ:PYXSPyxis Oncology Inc
06/07/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
05/30/20246:30AMGlobeNewswire Inc.Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare ConferenceNASDAQ:PYXSPyxis Oncology Inc
05/14/20247:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PYXSPyxis Oncology Inc
05/14/20246:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
05/14/20246:30AMGlobeNewswire Inc.Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024NASDAQ:PYXSPyxis Oncology Inc
05/09/20246:30AMGlobeNewswire Inc.Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare ConferenceNASDAQ:PYXSPyxis Oncology Inc
03/28/20243:30PMGlobeNewswire Inc.Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PYXSPyxis Oncology Inc
03/27/20246:30AMGlobeNewswire Inc.Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty RightsNASDAQ:PYXSPyxis Oncology Inc
03/21/20246:30AMGlobeNewswire Inc.Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023NASDAQ:PYXSPyxis Oncology Inc
03/13/20247:00AMGlobeNewswire Inc.Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFANASDAQ:PYXSPyxis Oncology Inc
03/08/20243:03PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PYXSPyxis Oncology Inc
03/07/20243:30PMGlobeNewswire Inc.Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024NASDAQ:PYXSPyxis Oncology Inc
03/05/20243:45PMGlobeNewswire Inc.Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual MeetingNASDAQ:PYXSPyxis Oncology Inc
02/28/20246:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
02/27/20247:00AMGlobeNewswire Inc.Pyxis Oncology Announces $50 Million Private PlacementNASDAQ:PYXSPyxis Oncology Inc
12/29/20233:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
12/29/20233:30PMGlobeNewswire Inc.Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PYXSPyxis Oncology Inc
12/06/20233:50PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
11/30/20233:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
11/28/20236:22AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
11/28/20236:00AMGlobeNewswire Inc.Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical OfficerNASDAQ:PYXSPyxis Oncology Inc
11/17/20233:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
11/07/20233:46PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PYXSPyxis Oncology Inc
11/07/20233:44PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
11/07/20233:30PMGlobeNewswire Inc.Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate UpdateNASDAQ:PYXSPyxis Oncology Inc
10/27/20233:34PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PYXSPyxis Oncology Inc
09/28/20233:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:PYXS

Your Recent History

USOTC
CNNA
Cann American (CE)
USOTC
RNVA
Rennova Health (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
RXMD
Progressive Care (QB)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
NLST
Netlist (QB)
USOTC
FNMA
Fannie Mae (QB)
COIN
SHIBUSD
SHIBA INU
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
GDVM
Global Developments (PK)
AMEX
SPY
SPDR S&P 500
USOTC
GTVH
Golden Triangle Ventures (PK)
USOTC
BLEG
Branded Legacy (PK)
NASDAQ
TSLA
Tesla
USOTC
ENZC
Enzolytics (PK)
USOTC
SMCE
SMC Entertainment (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved